Surname:
Elvira-Martínez Name: David
Birth: 16-08-1974 Telephone:+34675782777
E-Mail Address: davidelviramartinez@yahoo.com
Mail Address: Carrer Vinya, 5 (urb. Can Tolra). Cabrils 08348-
Barcelona. Spain
Professional Profile
Experienced health economist with strong institutional
background and in depth knowledge of market access and public affairs activities
in the pharmaceutical sector. With a great deal of experience in consultancy
activities at international level related to healthcare systems policies,
pharmaceutical business, healthcare reimbursement systems and economic evaluation
methods. Main responsibilities carrying out top management duties in several
public healthcare organizations and regional ministries in Spain as well as
lobbying entities. Advising at regional (Catalonia), national (Spain) and
international (World Health Organization) level for healthcare policy planning
and financing. 12 years as an Adjunct Faculty Professor in several universities
in Spain with over 20 scientific publications and experience as a visiting
researcher overseas.
Career Summary
04/2014 to present Sanofi
Spain - Portugal
Head of Public Affairs and Field Market
Access (member of the Affiliate’s Management Committee)
-
In charge of an 11 member team, 5 direct
reports.
-
Responsible for company’s price &
reimbursement activities at national level.
-
Responsible for the coordination of the
Key Institutional Management team at regional level.
-
Responsible for the design and
implementation of the institutional strategy of the company’s national and
regional “Market Access Plan”.
-
Responsible for the design and
implementation of the company’s “Corporate Affairs Plan”.
07/2011 to 04/ 2014 Sanofi
Spain - Portugal
Corporate Relations Regional Director
-
In charge of a 5 member team.
-
Responsible for the design and
implementation of the institutional strategy of the company’s regional “Market
Access Plan” in 4 of the key Spanish Regions (Catalonia, Andalucía,
Extremadura, Comunidad Valenciana: 50% of the national market).
-
Company’s institutional representative in
Catalonia, coordinating the corporative activities with top healthcare
authorities and payers (Regional Prime Minister, Regional Health Minister,
Regional Pharmacy Director).
-
Responsible for the design of the first
company’s “Regional Access Plan”.
-
Responsible for the design of the
institutional regional strategy to ensure the successful launch for Aflibercept
- Zaltrap©.
-
Interim Health Economics and Outcomes
Research - HEOR Director during one year: product value dossiers coordination,
economic evaluation modelling and HEOR publication strategy coordination.
01/2011 to 07/ 2011 Catalan Health Quality
and Assessment Agency (AQuAS)
Catalan Health Observatory Director &
Regional HTA Assessment Director
-
In charge of a 20 member team. 5 direct
reports.
-
Responsible for the regional
pharmaceutical and health technology assessment policy.
-
Regional Healthcare Ministry adviser for
the effective reimbursement of new drugs and healthcare technologies.
-
Responsible for the design and
implementation of the new Catalan Health Observatory including the Annual
Regional Health Report (to be presented annually at the Catalan Parliament) and
the Annual Providers Outcomes Report (including the quality benchmark study
among the 63 public financed Catalan hospitals).
08/2005 to 07/ 2011 Catalan Health Ministry
Healthcare Resources General Director
-
In charge of an 80 member team. 6 direct
reports. 7M€ of budget.
-
Responsible in Catalonia (7,5M people) for
the definition and implementation of: the Pharmaceutical Policy (medicines assessment, efficient use of
pharmaceutical products, pharmaceutical industrial affairs, industrial sites quality
inspection, pharmaceutical publicity regulation, hospital’s ethical committees coordination,
community pharmacies regulation & planning); Healthcare Center Official Accreditation
Model; Healthcare Quality & Inspection
Policy and Coordinator of the Regional Bioethics Committee.
-
Member of the Catalan Health Ministry’s
Board of Directors (budget: 9.800M€)
-
Vice President of the Catalan Blood and
Tissue Bank (600 employees and 84M€ of budget)
Head of the Information and Strategy
Cabinet (Health Minister’s Cabinet Office)
-
In charge of a 5 member team.
-
Responsible for the Institutional Affairs
of the Health Ministry (Spanish and Catalan Parliament as well as national and
regional Ombudsman).
-
Ministry’s coordinator of the development
and approval of 3 regional laws in Parliament.
-
Head of Minister’s Speech Writing process.
-
Ministry’s Healthcare Policy Scorecard
Coordinator.
-
Head of Healthcare Strategic Reports
production process.
Head of the Interdepartmental Information
Office
-
Health Ministry’s Information System (IS)
Coordinator.
-
Responsible for the correct execution of
Ministry’s IS key projects: Electronic Prescription Model, Electronic Clinical
Record Model, Ministry’s Scorecard and Telemedicine Policy.
-
Responsible for the Annual Health Data
Report.
-
Responsible for the definition of the
Catalan Strategic Health Plan’s KPI system.
10/2004 to 08/ 2005 HORE Group (today: HEOR’s
IMS Division in Spain)
Deputy General Director and Health Policy
& Economics Director
-
In charge of a 10 member team. 2 direct
reports.
-
Responsible for the client management and deliverables
coordination of health economics and health policy consultancy projects (international
pharmaceutical companies as main clients).
-
Responsible for the coordination of the general
human resources, financial and expansion policy of the company.
04/2001 to 10/ 2004 Gesaworld SA
International Consulting Deputy Director
-
Head and coordinator of the backoffice
activities of the company (proposals coordinator, quality and innovation
officer and consultants controller).
-
Front office senior consultant in
healthcare policy and planning key projects in Spain and Mexico. Projects mainly
financed by the Catalan Health Ministry, the World Bank and the Inter-American
Development Bank.
Academic Profile
QUALIFICATIONS
|
CENTER
|
DATE
|
Doctoral Dissertation in process: “Synthetic Hospital Quality
Indicator: a structural equation’s approach”
|
Autonomous University of Barcelona - UAB
|
January 1999
April 2004 (research project registration)
|
MSc in Applied Economics
|
Autonomous University of Barcelona - UAB
|
June 1998
|
BA in Economics
|
Pompeu Fabra University – UPF (Barcelona)
|
June 1996
|
Other merits
-
From October 2013: Member of the Catalan’s President’s Health Policy Advisory Board (CASOST).
-
From April 2001: research collaborator of the Economics and Health Research Centre
(CRES) at Pompeu Fabra University.
-
From January 2002: member of AES (Spanish health Economics Association) and member of IHEA (International Health Economics
Association).
-
From 2010 to 2011: Catalan Health Ministry delegate at the Healthcare Sustainability Task
Force Group.
-
From 2010 to 2011: Member of the Board of the Catalan Health Quality Agency.
-
From 2010 to 2011: Member of the Board of the Catalan Statistics Institute.
-
From 2010 to 2011: Member of the Board of the Catalan Pharmacology Institute.
-
From January 2002: Adjunct Faculty Professor of Economics at Pompeu Fabra University (UPF).
-
From January 2002 to January 2004: Technical Director of Edad&Vida
(Economic Lobby).
-
From March 2005: Faculty Health Policy Professor at the MSc on Clinical Management at
Catalonia Open University (UOC).
-
WHO-World Health Organization’s Consultant in Spain, Montenegro and Andorra (2011).
-
From 1999 to 2000: International Visitor Researcher at Keio-Tokyo and Kyoto Universities.
Entrades
